Characterization of Spironolactone and Metabolites Derivatized Using Girard's Reagent P with Mass Spectrometry and Ion Mobility Spectrometry

    Stephanie M. Jones, Kaylie I. Kirkwood‐Donelson, Georgia M. Alexander, L. Perera, Serena M. Dudek, Alan K. Jarmusch
    New to Spironolactone? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study demonstrated that GP derivatization improves mass spectral analysis of spironolactone and its metabolites by reducing in-source fragmentation and enhancing signal clarity, laying the groundwork for future advancements in reaction optimization and quantitative assay development.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results